StockNews.com Initiates Coverage on Taro Pharmaceutical Industries (NYSE:TARO)

Equities research analysts at StockNews.com began coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO) in a research report issued on Tuesday. The brokerage set a “strong-buy” rating on the stock.

Taro Pharmaceutical Industries Stock Up 0.6 %

Shares of NYSE:TARO opened at $42.78 on Tuesday. The company has a market cap of $1.61 billion, a price-to-earnings ratio of 29.71 and a beta of 0.60. The business has a 50 day moving average price of $42.27 and a 200 day moving average price of $41.06. Taro Pharmaceutical Industries has a twelve month low of $28.10 and a twelve month high of $45.76.

Institutional Investors Weigh In On Taro Pharmaceutical Industries

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Strs Ohio boosted its holdings in Taro Pharmaceutical Industries by 385.2% in the 4th quarter. Strs Ohio now owns 13,100 shares of the company’s stock valued at $547,000 after purchasing an additional 10,400 shares during the period. SG Americas Securities LLC grew its position in Taro Pharmaceutical Industries by 24.5% during the fourth quarter. SG Americas Securities LLC now owns 4,673 shares of the company’s stock worth $195,000 after buying an additional 921 shares in the last quarter. FNY Investment Advisers LLC acquired a new position in Taro Pharmaceutical Industries in the 4th quarter valued at approximately $105,000. Invesco Ltd. bought a new stake in shares of Taro Pharmaceutical Industries in the 3rd quarter worth approximately $9,995,000. Finally, Allspring Global Investments Holdings LLC grew its holdings in shares of Taro Pharmaceutical Industries by 332.1% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 7,467 shares of the company’s stock worth $312,000 after purchasing an additional 5,739 shares in the last quarter. Institutional investors and hedge funds own 91.40% of the company’s stock.

Taro Pharmaceutical Industries Company Profile

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products.